Literature DB >> 16337490

Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis.

Lise Bathum1, Heidi Hansen, Børge Teisner, Claus Koch, Peter Garred, Kirsten Rasmussen, Palle Wang.   

Abstract

BACKGROUND: Individuals genetically deficient of properdin are more susceptible to meningococcal disease. Likewise low concentration or decreased biological activity of mannose-binding lectin (MBL) is associated with higher incidence of bacterial infections during childhood. In this study we report our findings in a Danish family with a remarkably high incidence of meningococcal meningitis-in total four cases, one of them fatal.
METHODS: Properdin and MBL were quantified by ELISA and the properdin gene was screened for sequence variations using denaturing high-performance liquid chromatography (DHPLC) and subsequent sequencing of abnormal patterns. The MBL gene was genotyped for the three known variant alleles (B, C and D) as well as three promoter polymorphisms (-221Y/X, -550H/L and +4P/Q).
RESULTS: Two out of six males with undetectable properdin activity had meningitis. They had also low MBL serum levels or carried an MBL variant allele, whereas high MBL concentrations were measured in three out of four properdin deficient males--without meningitis. A splice site mutation in exon 10 (c.1487-2A>G) was found in the properdin gene and co segregated with biochemically measured properdin deficiency.
CONCLUSION: Our results indicate that a combined deficiency of both properdin and MBL increases the risk of infection with Neisseria meningitidis and stress the importance of epistatic genetic interactions in disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337490     DOI: 10.1016/j.molimm.2005.02.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.

Authors:  Yuko Kimura; Lin Zhou; Takashi Miwa; Wen-Chao Song
Journal:  J Clin Invest       Date:  2010-10       Impact factor: 14.808

2.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

3.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

Review 4.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Novel assays to assess the functional capacity of the classical, the alternative and the lectin pathways of the complement system.

Authors:  Y Palarasah; C Nielsen; U Sprogøe; M L Christensen; S Lillevang; H O Madsen; A Bygum; C Koch; K Skjodt; M-O Skjoedt
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

6.  A novel mutation W388X underlying properdin deficiency in a Finnish family.

Authors:  M Helminen; S Seitsonen; H Jarva; S Meri; I E Järvelä
Journal:  Scand J Immunol       Date:  2012-04       Impact factor: 3.487

7.  Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors:  Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

8.  Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage.

Authors:  Mary C Walsh; Lisa A Shaffer; Benjamin J Guikema; Simon C Body; Stanton K Shernan; Amanda A Fox; Charles D Collard; Michael Fung; Ronald P Taylor; Gregory L Stahl
Journal:  J Immunol Methods       Date:  2007-05-11       Impact factor: 2.303

9.  Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury.

Authors:  Masayuki Ozaki; Yulin Kang; Ying Siow Tan; Vasile I Pavlov; Bohan Liu; Daniel C Boyle; Rafail I Kushak; Mikkel-Ole Skjoedt; Eric F Grabowski; Yasuhiko Taira; Gregory L Stahl
Journal:  Kidney Int       Date:  2016-07-01       Impact factor: 10.612

10.  Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.

Authors:  Anja Fuchs; Tsai-Yu Lin; David W Beasley; Cordula M Stover; Wilhelm J Schwaeble; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2010-08-19       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.